Zeuzem, S; Alberti, A; Rosenberg, W; Marcellin, P; Diago, M; Negro, F; ... Shiffman, ML; + view all Zeuzem, S; Alberti, A; Rosenberg, W; Marcellin, P; Diago, M; Negro, F; Prati, D; Puoti, C; Roberts, SK; Shiffman, ML; - view fewer (2006) Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity. Aliment Pharmacol Ther , 24 (8) 1133 - 1149. 10.1111/j.1365-2036.2006.03073.x.
Full text not available from this repository.
Hepatitis C virus infection, a major cause of chronic liver disease, occurs with normal serum alanine aminotransferase activity in approximately 25% of patients. These patients have historically remained untreated but substantial evidence indicates liver damage, progression of disease and impaired quality of life in some individuals.
|Title:||Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity.|
|Keywords:||Alanine Transaminase, Antiviral Agents, Drug Therapy, Combination, Genotype, Health Care Costs, Hepatitis C, Chronic, Humans, Interferon-alpha, Liver, Motivation, Polyethylene Glycols, Prognosis, Recombinant Proteins, Ribavirin|
Archive Staff Only: edit this record